We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TRPX market cap is 223.8k. The company's latest EPS is USD -7.2550 and P/E is -0.17.
Quarter End | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.86M | -1.51M | -1.9M | -2.13M | -1.85M |
Net Income | -1.56M | -1.51M | -1.97M | -2.05M | -2.14M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 1.35M | 2.88M |
Operating Income | -4.11M | -2.55M | -5.77M | -8.4M | -7.03M |
Net Income | -4.48M | -3.48M | -5.79M | -2.59M | -5.12M |
Quarter End | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.64M | 444k | 5.05M | 8.06M | 4.57M |
Total Liabilities | 1.49M | 1.79M | 1.58M | 1.56M | 5.42M |
Total Equity | 2.15M | -1.34M | 3.48M | 6.5M | -850k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.15M | 2.56M | 9.92M | 10.61M | 11.18M |
Total Liabilities | 1.14M | 1.13M | 1.78M | 4.16M | 1.6M |
Total Equity | 14k | 1.43M | 8.14M | 6.45M | 9.59M |
Quarter End | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2018 | Mar 2019 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.33M | -691k | -1.31M | -1.63M | N/A |
Investing | N/A | 2k | -13k | -9k | N/A |
Financing | N/A | 272k | N/A | -37k | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.7M | -4.31M | -5.06M | -7.92M | -5.89M |
Investing | 1.27M | 24k | -70k | -7.08M | -1.11M |
Financing | 2.8M | 5.36M | 10.06M | 11.7M | 5.5M |
Market Cap | 223.8k |
Price to Earnings Ratio | -0.17 |
Price to Sales Ratio | 0.3 |
Price to Cash Ratio | 0.42 |
Price to Book Ratio | 0.09 |
Dividend Yield | - |
Shares Outstanding | 706k |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (1.56%) |
Company Name | Therapix Biosciences Ltd |
Address |
20 raul wallenberg st., tower a, 2nd floor tel aviv, center 6971916 |
Website | https://scisparc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions